Global Opioid-Induced Constipation Market Status, Trends and COVID-19 Impact Report 2022

Publication Month: Mar 2023 | No. of Pages: 125 Published By: BisReport
Single User License: US $ 2350
Corporate User License: US $ 4700

Global Opioid-Induced Constipation Market Status, Trends and COVID-19 Impact Report 2022
Single User License Report: 2350 USD
Corporate User License Report: 4700 USD
Section Price: As below
Page: 118
Chart and Figure: 150
Publisher: BisReport
Delivery Time: 48 hour
Contact: sales@bisreport.com
Phone: +86-18612563964

In the past few years, the Opioid-Induced Constipation market experienced a huge change under the influence of COVID-19 and Russia-Ukraine War, the global market size of Opioid-Induced Constipation reached 2230.0 million $ in 2022 from 1800.0 in 2017 with a CAGR of 0.043773992885 from 2017-2022. Facing the complicated international situation, the future of the Opioid-Induced Constipation market is full of uncertain. BisReport predicts that the global Opioid-Induced Constipation market size will reach 2800.0 million $in 2028 with a CAGR of xx% from 2022-2028.

Since the outbreak of COVID-19, the world economy continues to suffer from a series of destabilizing shocks, many companies experienced bankruptcy and a sharp decline in turnover. After more than two years of pandemic, global economy began to recover, entering 2022, the Russian Federation's invasion of Ukraine and its global effects on commodity markets, supply chains, inflation, and financial conditions have steepened the slowdown in global growth. In particular, the war in Ukraine is leading to soaring prices and volatility in energy markets, with improvements in activity in energy exporters more than offset by headwinds to activity in most other economies. The invasion of Ukraine has also led to a significant increase in agricultural commodity prices, which is exacerbating food insecurity and extreme poverty in many emerging market and developing economies.

Numerous risks could further derail what is now a precarious recovery. Among them is, in particular, the possibility of stubbornly high global inflation accompanied by tepid growth, reminiscent of the stagflation of the 1970s. This could eventually result in a sharp tightening of monetary policy in advanced economies to rein in inflation, lead to surging borrowing costs, and possibly culminate in financial stress in some emerging market and developing economies. A forceful and wide-ranging policy response is required by policy makers in these economies and the global community to boost growth, bolster macroeconomic frameworks, reduce financial vulnerabilities, provide support to vulnerable population groups, and attenuate the long-term impacts of the global shocks of recent years.

In this complex international situation, BisReport published Global Opioid-Induced Constipation Market Status, Trends and COVID-19 Impact Report 2022, which provides a comprehensive analysis of the global Opioid-Induced Constipation market , This Report covers the manufacturer data, including: sales volume, price, revenue, gross margin, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows the regional development status, including market size, volume and value, as well as price data. Besides, the report also covers segment data, including: type segment, application segment, channel segment etc. historic data period is from 2017-2022, the forecast data from 2023-2028.

Section 1: 100 USD——Market Overview

Section (2 3): 1200 USD——Manufacturer Detail
Takeda Pharmaceuticals
Bayer
Sanofi
Mallinckrodt
Salix (Bausch Health)
AstraZeneca
Progenics Pharmaceuticals
Purdue Pharm
Nektar Therapeutics
Daiichi Sankyo
Prestige
GSK
Shionogi

Section 4: 900 USD——Region Segment
North America (United States, Canada, Mexico)
South America (Brazil, Argentina, Other)
Asia Pacific (China, Japan, India, Korea, Southeast Asia)
Europe (Germany, UK, France, Spain, Russia, Italy)
Middle East and Africa (Middle East, South Africa, Egypt)

Section (5 6 7): 700 USD——
Product Type Segment
Methylnaltrexone Bromide
Lubiprostone
Naloxegol

Application Segment
Hospital
Pharmacy

Channel Segment (Direct Sales, Distribution Channel)

Section 8: 500 USD——Market Forecast (2023-2028)

Section 9: 600 USD——Downstream Customers

Section 10: 200 USD——Raw Material and Manufacturing Cost

Section 11: 500 USD——Conclusion

Section 12: Research Method and Data Source

Table of Contents
Section 1 Opioid-Induced Constipation Market Overview
1.1 Opioid-Induced Constipation Market Scope
1.2 COVID-19 Impact on Opioid-Induced Constipation Market
1.3 Global Opioid-Induced Constipation Market Status and Forecast Overview
1.3.1 Global Opioid-Induced Constipation Market Status 2017-2022
1.3.2 Global Opioid-Induced Constipation Market Forecast 2023-2028
1.4 Global Opioid-Induced Constipation Market Overview by Region
1.5 Global Opioid-Induced Constipation Market Overview by Type
1.6 Global Opioid-Induced Constipation Market Overview by Application

Section 2 Global Opioid-Induced Constipation Market Manufacturer Share
2.1 Global Manufacturer Opioid-Induced Constipation Sales Volume
2.2 Global Manufacturer Opioid-Induced Constipation Business Revenue
2.3 Global Manufacturer Opioid-Induced Constipation Price

Section 3 Manufacturer Opioid-Induced Constipation Business Introduction
3.1 Takeda Pharmaceuticals Opioid-Induced Constipation Business Introduction
3.1.1 Takeda Pharmaceuticals Opioid-Induced Constipation Sales Volume, Price, Revenue and Gross margin 2017-2022
3.1.2 Takeda Pharmaceuticals Opioid-Induced Constipation Business Distribution by Region
3.1.3 Takeda Pharmaceuticals Interview Record
3.1.4 Takeda Pharmaceuticals Opioid-Induced Constipation Business Profile
3.1.5 Takeda Pharmaceuticals Opioid-Induced Constipation Product Specification

3.2 Bayer Opioid-Induced Constipation Business Introduction
3.2.1 Bayer Opioid-Induced Constipation Sales Volume, Price, Revenue and Gross margin 2017-2022
3.2.2 Bayer Opioid-Induced Constipation Business Distribution by Region
3.2.3 Interview Record
3.2.4 Bayer Opioid-Induced Constipation Business Overview
3.2.5 Bayer Opioid-Induced Constipation Product Specification

3.3 Manufacturer three Opioid-Induced Constipation Business Introduction
3.3.1 Manufacturer three Opioid-Induced Constipation Sales Volume, Price, Revenue and Gross margin 2017-2022
3.3.2 Manufacturer three Opioid-Induced Constipation Business Distribution by Region
3.3.3 Interview Record
3.3.4 Manufacturer three Opioid-Induced Constipation Business Overview
3.3.5 Manufacturer three Opioid-Induced Constipation Product Specification

3.4 Manufacturer four Opioid-Induced Constipation Business Introduction
3.4.1 Manufacturer four Opioid-Induced Constipation Sales Volume, Price, Revenue and Gross margin 2017-2022
3.4.2 Manufacturer four Opioid-Induced Constipation Business Distribution by Region
3.4.3 Interview Record
3.4.4 Manufacturer four Opioid-Induced Constipation Business Overview
3.4.5 Manufacturer four Opioid-Induced Constipation Product Specification

3.5
3.6


Section 4 Global Opioid-Induced Constipation Market Segment (By Region)
4.1 North America Country
4.1.1 United States Opioid-Induced Constipation Market Size and Price Analysis 2017-2022
4.1.2 Canada Opioid-Induced Constipation Market Size and Price Analysis 2017-2022
4.1.3 Mexico Opioid-Induced Constipation Market Size and Price Analysis 2017-2022
4.2 South America Country
4.2.1 Brazil Opioid-Induced Constipation Market Size and Price Analysis 2017-2022
4.2.2 Argentina Opioid-Induced Constipation Market Size and Price Analysis 2017-2022
4.3 Asia Pacific
4.3.1 China Opioid-Induced Constipation Market Size and Price Analysis 2017-2022
4.3.2 Japan Opioid-Induced Constipation Market Size and Price Analysis 2017-2022
4.3.3 India Opioid-Induced Constipation Market Size and Price Analysis 2017-2022
4.3.4 Korea Opioid-Induced Constipation Market Size and Price Analysis 2017-2022
4.3.5 Southeast Asia Opioid-Induced Constipation Market Size and Price Analysis 2017-2022
4.4 Europe Country
4.4.1 Germany Opioid-Induced Constipation Market Size and Price Analysis 2017-2022
4.4.2 UK Opioid-Induced Constipation Market Size and Price Analysis 2017-2022
4.4.3 France Opioid-Induced Constipation Market Size and Price Analysis 2017-2022
4.4.4 Spain Opioid-Induced Constipation Market Size and Price Analysis 2017-2022
4.4.5 Russia Opioid-Induced Constipation Market Size and Price Analysis 2017-2022
4.4.6 Italy Opioid-Induced Constipation Market Size and Price Analysis 2017-2022
4.5 Middle East and Africa
4.5.1 Middle East Opioid-Induced Constipation Market Size and Price Analysis 2017-2022
4.5.2 South Africa Opioid-Induced Constipation Market Size and Price Analysis 2017-2022
4.5.3 Egypt Opioid-Induced Constipation Market Size and Price Analysis 2017-2022
4.6 Global Opioid-Induced Constipation Market Segment (By Region) Analysis 2017-2022
4.7 Global Opioid-Induced Constipation Market Segment (By Country) Analysis 2017-2022
4.8 Global Opioid-Induced Constipation Market Segment (By Region) Analysis

Section 5 Global Opioid-Induced Constipation Market Segment (by Product Type)
5.1 Product Introduction by Type
5.1.1 Methylnaltrexone Bromide Product Introduction
5.1.2 Lubiprostone Product Introduction
5.1.3 Naloxegol Product Introduction
5.2 Global Opioid-Induced Constipation Sales Volume (by Type) 2017-2022
5.3 Global Opioid-Induced Constipation Market Size (by Type) 2017-2022
5.4 Different Opioid-Induced Constipation Product Type Price 2017-2022
5.5 Global Opioid-Induced Constipation Market Segment (By Type) Analysis

Section 6 Global Opioid-Induced Constipation Market Segment (by Application)
6.1 Global Opioid-Induced Constipation Sales Volume (by Application) 2017-2022
6.2 Global Opioid-Induced Constipation Market Size (by Application) 2017-2022
6.3 Opioid-Induced Constipation Price in Different Application Field 2017-2022
6.4 Global Opioid-Induced Constipation Market Segment (By Application) Analysis

Section 7 Global Opioid-Induced Constipation Market Segment (by Channel)
7.1 Global Opioid-Induced Constipation Market Segment (By Channel) Sales Volume and Share 2017-2022
7.2 Global Opioid-Induced Constipation Market Segment (By Channel) Analysis

Section 8 Global Opioid-Induced Constipation Market Forecast 2023-2028
8.1 Opioid-Induced Constipation Segment Market Forecast 2023-2028 (By Region)
8.2 Opioid-Induced Constipation Segment Market Forecast 2023-2028 (By Type)
8.3 Opioid-Induced Constipation Segment Market Forecast 2023-2028 (By Application)
8.4 Opioid-Induced Constipation Segment Market Forecast 2023-2028 (By Channel)

8.5 Global Opioid-Induced Constipation Price (USD/Unit) Forecast
Section 9 Opioid-Induced Constipation Application and Customer Analysis
9.1 Hospital Customers
9.2 Pharmacy Customers

Section 10 Opioid-Induced Constipation Manufacturing Cost of Analysis
10.1 Raw Material Cost Analysis
10.2 Labor Cost Analysis
10.3 Cost Overview

Section 11 Conclusion

12 Research Method and Data Source

Chart and Figure
Figure Opioid-Induced Constipation Product Picture
Chart Global Opioid-Induced Constipation Market Size (with or without the impact of COVID-19)
Chart Global Opioid-Induced Constipation Sales Volume (Units) and Growth Rate 2017-2022
Chart Global Opioid-Induced Constipation Market Size (Million $) and Growth Rate 2017-2022
Chart Global Opioid-Induced Constipation Sales Volume (Units) and Growth Rate 2023-2028
Chart Global Opioid-Induced Constipation Market Size (Million $) and Growth Rate 2023-2028
Table Global Opioid-Induced Constipation Market Overview by Region
Table Global Opioid-Induced Constipation Market Overview by Type
Table Global Opioid-Induced Constipation Market Overview by Application
Chart 2017-2022 Global Manufacturer Opioid-Induced Constipation Sales Volume (Units)
Chart 2017-2022 Global Manufacturer Opioid-Induced Constipation Sales Volume Share
Chart 2017-2022 Global Manufacturer Opioid-Induced Constipation Business Revenue (Million USD)
Chart 2017-2022 Global Manufacturer Opioid-Induced Constipation Business Revenue Share
Chart 2017-2022 Global Manufacturer Opioid-Induced Constipation Business Price (USD/Unit)
Chart Takeda Pharmaceuticals Opioid-Induced Constipation Sales Volume, Price, Revenue and Gross margin 2017-2022
Chart Takeda Pharmaceuticals Opioid-Induced Constipation Business Distribution
Chart Takeda Pharmaceuticals Interview Record (Partly)
Chart Takeda Pharmaceuticals Opioid-Induced Constipation Business Profile
Table Takeda Pharmaceuticals Opioid-Induced Constipation Product Specification


Chart United States Opioid-Induced Constipation Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart United States Opioid-Induced Constipation Sales Price (USD/Unit) 2017-2022
Chart Canada Opioid-Induced Constipation Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Canada Opioid-Induced Constipation Sales Price (USD/Unit) 2017-2022
Chart Mexico Opioid-Induced Constipation Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Mexico Opioid-Induced Constipation Sales Price (USD/Unit) 2017-2022
Chart Brazil Opioid-Induced Constipation Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Brazil Opioid-Induced Constipation Sales Price (USD/Unit) 2017-2022
Chart Argentina Opioid-Induced Constipation Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Argentina Opioid-Induced Constipation Sales Price (USD/Unit) 2017-2022
Chart China Opioid-Induced Constipation Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart China Opioid-Induced Constipation Sales Price (USD/Unit) 2017-2022
Chart Japan Opioid-Induced Constipation Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Japan Opioid-Induced Constipation Sales Price (USD/Unit) 2017-2022
Chart India Opioid-Induced Constipation Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart India Opioid-Induced Constipation Sales Price (USD/Unit) 2017-2022
Chart Korea Opioid-Induced Constipation Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Korea Opioid-Induced Constipation Sales Price (USD/Unit) 2017-2022
Chart Southeast Asia Opioid-Induced Constipation Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Southeast Asia Opioid-Induced Constipation Sales Price (USD/Unit) 2017-2022
Chart Germany Opioid-Induced Constipation Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Germany Opioid-Induced Constipation Sales Price (USD/Unit) 2017-2022
Chart UK Opioid-Induced Constipation Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart UK Opioid-Induced Constipation Sales Price (USD/Unit) 2017-2022
Chart France Opioid-Induced Constipation Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart France Opioid-Induced Constipation Sales Price (USD/Unit) 2017-2022
Chart Spain Opioid-Induced Constipation Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Spain Opioid-Induced Constipation Sales Price (USD/Unit) 2017-2022
Chart Russia Opioid-Induced Constipation Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Russia Opioid-Induced Constipation Sales Price (USD/Unit) 2017-2022
Chart Italy Opioid-Induced Constipation Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Italy Opioid-Induced Constipation Sales Price (USD/Unit) 2017-2022
Chart Middle East Opioid-Induced Constipation Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Middle East Opioid-Induced Constipation Sales Price (USD/Unit) 2017-2022
Chart South Africa Opioid-Induced Constipation Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart South Africa Opioid-Induced Constipation Sales Price (USD/Unit) 2017-2022
Chart Egypt Opioid-Induced Constipation Sales Volume (Units) and Market Size (Million $) 2017-2022
Chart Egypt Opioid-Induced Constipation Sales Price (USD/Unit) 2017-2022
Chart Global Opioid-Induced Constipation Market Segment Sales Volume (Units) by Region 2017-2022
Chart Global Opioid-Induced Constipation Market Segment Sales Volume (Units) Share by Region 2017-2022
Chart Global Opioid-Induced Constipation Market Segment Market size (Million $) by Region 2017-2022
Chart Global Opioid-Induced Constipation Market Segment Market size (Million $) Share by Region 2017-2022
Chart Global Opioid-Induced Constipation Market Segment Sales Volume (Units) by Country 2017-2022
Chart Global Opioid-Induced Constipation Market Segment Sales Volume (Units) Share by Country 2017-2022
Chart Global Opioid-Induced Constipation Market Segment Market size (Million $) by Country 2017-2022
Chart Global Opioid-Induced Constipation Market Segment Market size (Million $) Share by Country 2017-2022
Chart Methylnaltrexone Bromide Product Figure
Chart Methylnaltrexone Bromide Product Description
Chart Lubiprostone Product Figure
Chart Lubiprostone Product Description
Chart Naloxegol Product Figure
Chart Naloxegol Product Description
Chart Opioid-Induced Constipation Sales Volume by Type (Units) 2017-2022
Chart Opioid-Induced Constipation Sales Volume (Units) Share by Type
Chart Opioid-Induced Constipation Market Size by Type (Million $) 2017-2022
Chart Opioid-Induced Constipation Market Size (Million $) Share by Type
Chart Different Opioid-Induced Constipation Product Type Price (USD/Unit) 2017-2022
Chart Opioid-Induced Constipation Sales Volume by Application (Units) 2017-2022
Chart Opioid-Induced Constipation Sales Volume (Units) Share by Application
Chart Opioid-Induced Constipation Market Size by Application (Million $) 2017-2022
Chart Opioid-Induced Constipation Market Size (Million $) Share by Application
Chart Opioid-Induced Constipation Price in Different Application Field 2017-2022
Chart Global Opioid-Induced Constipation Market Segment (By Channel) Sales Volume (Units) 2017-2022
Chart Global Opioid-Induced Constipation Market Segment (By Channel) Share 2017-2022
Chart Opioid-Induced Constipation Segment Market Sales Volume (Units) Forecast (by Region) 2023-2028
Chart Opioid-Induced Constipation Segment Market Sales Volume Forecast (By Region) Share 2023-2028
Chart Opioid-Induced Constipation Segment Market Size (Million USD) Forecast (By Region) 2023-2028
Chart Opioid-Induced Constipation Segment Market Size Forecast (By Region) Share 2023-2028
Chart Opioid-Induced Constipation Market Segment (By Type) Volume (Units) 2023-2028
Chart Opioid-Induced Constipation Market Segment (By Type) Volume (Units) Share 2023-2028
Chart Opioid-Induced Constipation Market Segment (By Type) Market Size (Million $) 2023-2028
Chart Opioid-Induced Constipation Market Segment (By Type) Market Size (Million $) 2023-2028
Chart Opioid-Induced Constipation Market Segment (By Application) Market Size (Volume) 2023-2028
Chart Opioid-Induced Constipation Market Segment (By Application) Market Size (Volume) Share 2023-2028
Chart Opioid-Induced Constipation Market Segment (By Application) Market Size (Value) 2023-2028
Chart Opioid-Induced Constipation Market Segment (By Application) Market Size (Value) Share 2023-2028
Chart Global Opioid-Induced Constipation Market Segment (By Channel) Sales Volume (Units) 2023-2028
Chart Global Opioid-Induced Constipation Market Segment (By Channel) Share 2023-2028
Chart Global Opioid-Induced Constipation Price Forecast 2023-2028
Chart Hospital Customers
Chart Pharmacy Customers



Tables and Figures



Reason to Buy

  • Current and future of Machinery & Equipment Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Machinery & Equipment Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Machinery & Equipment Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Machinery & Equipment Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets